Fiscal first quarter sales ending December 31, 2014, for Brooks Automation Life Science Systems (LSS) grew 36.8%, 7.3% excluding the acquisition of FluidX (see IBO 10/15/14), to $16.7 million (see page 12) to account for 14% of company sales. Product revenue grew 56.9%, 12.7% excluding the acquisition, to account for 77% of LSS revenue. LSS […]
Fourth quarter 2014 IBO Lab Equipment/Consumables Sales Index revenues grew 4.6%, 6.3% excluding currency, to $4,679 million. Growth was driven by strong results for Thermo Fisher Scientific Laboratory Products and Services (LPS). Index adjusted operating profit improved only 0.3% to $811 million. Operating margin declined 70 basis points to 15.7% of sales due to divestments, […]
Washington, DC 4/6/15—OpGen has disclosed in an SEC filing for its IPO (see IBO 3/15/15) that it plans to offer 3,750,000 shares of common stock at a price of $8–$10 per share. Assuming a price of $9 per share, the company expects to raise $30.5 million, or $35 million if underwriters exercise their option.
With the completed acquisition of Life Technologies (see IBO 2/15/14) in 2014, Thermo Fisher Scientific further solidified its number one position among IBO’s list of the top 30 analytical and life science instrument, aftermarket and lab product companies. All sales and sales growth figures in this article are based on IBO’s calculations of companies’ revenues […]
Financials for the IBO Laboratory Sales Index have been updated from the February 15 issue to include all the companies. Fourth quarter 2014 Laboratory Sales Index sales grew 3.8%, 6.1% organically, to $7,287 million. Operating profit climbed 7.7% to $1,748 million, and operating margin advanced 220 basis points to 21.3% of sales. For 2014, Index […]
In March, the US Office of Science and Technology Policy (OSTP) issued a report on the budget authority for federal R&D-facilities construction and major capital equipment (R&D infrastructure) in President Obama’s fiscal year 2016 (FY16) budget. The report included actual FY14 and estimated FY15 budget authorities for R&D infrastructure, which is defined as support for […]
US equity markets wavered in March due to the Federal Reserve’s ambiguous wordplay on raising interest rates and concerns over corporate profits due to the strengthening US dollar. The Fed continues to be unnerved by the fragility of the economy and growing market risks associated with loose monetary policies. The latest US GDP estimate for […]
Jena, Germany 3/26/15—Germany’s Analytik Jena delisted its shares from the Frankfurt Stock Exchange effective March 26 (see IBO 9/30/14). “The shareholder structure means that Analytik Jena AG does not have to be listed on the stock exchange anymore,” stated Analytik CEO Klaus Berka. “In particular, we no longer rely on the possibility of raising capital […]
Published this month, the Congressional Research Service’s (CRS) report entitled “Federal Research and Development Funding: FY2016” provides updated government estimates for the fiscal year 2015 (FY15) (October 1, 2014–September 30, 2015) US federal government R&D budget. These numbers update the American Association for the Advancement of Science estimates for FY15 federal R&D spending published in […]
Company Announcements BioMérieux 2014 Industrial Applications revenue declined 0.9%, up 0.8% on a like-for-like basis, to €327 million ($436 million) to represent 19% of sales. Sales for Industrial Applications rose in all regions except China. R&D-related revenue was flat at €7 million ($9 million). GE Healthcare announced on its quarterly conference call that 2014 Life […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
